Intensive Care Unit Market

The changing structure of the global Health System that has moved away from viewing critical care services as exclusively hospital-based to viewing critical care as a primary measure of national resilience has greatly affected the way in which ICUs will continue to evolve. This change can be seen through the combination of many of the clinical, demographic, regulatory, and technological aspects that are now present in the way hospitals build capacity, introduce innovation, and allocate resources. For example, the percentage of hospital expenditures allocated to critical care, as well as the number of ICU beds available, has increased within OECD countries over the last ten years due to a higher level of complexity of patients and longer hospitalization periods with older population demographics. Likewise, as a continuation of the previous example, there is an increasing number of patients that will survive and continue to live with chronic conditions associated with these types of diseases based upon global population growth patterns.

Due to the increasing numbers of patients that die globally from septic shock/sepsis, there is also an increased demand for the products that provide respiratory and renal support for patients who have acute respiratory illnesses, cardiovascular instability, or severe bacterial infections. With evolving Federal and State governance structures in terms of clinical practice and emerging technologies, governments are investing heavily into building a digital healthcare infrastructure that supports the delivery of critical care services electronically while also improving the speed at which clinical care is delivered, improving patient safety, and improving clinical efficiencies. These governments are also developing new regulations that create a competitive marketplace for the development of AI systems, tele-ICU, and advanced life-support devices in the U.S., EU, and Asia-Pacific.

Currently, the primary medical reason for patients to be admitted to an Intensive Care Unit (ICU) is due to chronic illness (NCD) that is treated in the ICU. According to WHO (World Health Organization), chronic illnesses (NCDs) account for 74% of global mortality with the majority coming from 4 major chronic illnesses (cardiovascular disease, cancers, chronic respiratory disease, and diabetes). For example, in 2021, at least 19 million people died from cardiovascular disease, about 10 million from cancer, approximately 4 million from chronic respiratory disease, and over 2 million from diabetes (including those who developed kidney disease from diabetes). All of these chronic illnesses can result in acute symptoms, necessitating specialized care in an ICU, e.g. Myocardial Infarction with Cardiogenic Shock, Acute Stroke with Airway Compromise, Diabetic Ketoacidosis, and Acute-On-Chronic Respiratory Failure.
 
Furthermore, NCDs interact with both Infection and Surgery. An individual with an underlying chronic illness, such as uncontrolled diabetes or heart failure, will be at a higher likelihood of requiring Ventilatory Support and Hemodynamic Monitoring than an individual with neither chronic condition who acquires Pneumonia or undergoes emergency surgery. As previously stated, this “multi-hit pattern” of chronic disease/or acute insult is frequently mentioned in many NCD and Emergency-Care Policies as an argument for the need to increase capacity and resources for critical care at the same time as primary and preventive care services.

With increased access to essential surgical procedures, trauma care, and emergency care, demand for intensive care unit (ICU) capacity will increase as well. As the Lancet Commission on Global Surgery report indicates, approximately 5 billion of the world's population do not have adequate access to safe, affordable surgical and anesthesia services, specifically in low-to-middle-income countries (LMICs). The burden of disease due to surgical conditions, including trauma/injury, obstetric emergencies and cancers, is estimated to be approximately 28%-32% globally; and access to quality surgical care is severely limited in poor countries. Closing this surgical gap will result in many patients also receiving complex surgical interfaces and trauma care procedures, as well as obstetrical procedures, which often require perioperative ICU/high-dependency-unit level care for ventilation, invasive monitoring and hemodynamics support.

North America: Highly developed and technology-heavy ICU ecosystems

North America has some of the most highly developed and technology-heavy ICU ecosystems in the world. However, it also faces increasing structural limitations. In the U.S., a 2021 county-level study reported 79,876 critical care beds in 4,846 different hospitals with an average population density of 24-25 critical care beds per 100,000 citizens across the U.S., as well as significant geographic variation among counties. Historical SCCM data indicate a 17.8% growth of U.S. hospital critical care beds between 2000-2010, going from 88,235 in 2000 to 103,900 in 2010, which speaks to the long-term growth in capacity to care for the increasing demand. However, recent projections indicate that a capacity crisis is about to occur. A JAMA Network Open analysis summarized by The Washington Post indicates the total number of actively staffed hospital beds in the U.S. dropped from 802,000 in 2009 to 674,000 in 2024 while simultaneously the percentage of occupied beds increased from 63.9% to 75.3%. As many as 40 million people will be hospitalized every year by 2035, and occupancy rates will be close to 85%, a threshold that indicates unsafe operations. Thus, expanding ICU and high acuity bed capacity and staffing will remain priorities of Health Systems in the U.S.

Europe: Production technology-heavy ICU ecosystems

The ICU environment in Europe is comprised of a very broad scope of characteristics and standards, but it is ultimately a mature environment. A comprehensive European study conducted in 2021 estimated that there is a total of 73,585 ICU beds among the participating countries, which averages 11.5 ICU beds per 100,000 population across the participants, although there are clear disparities with the lowest number of ICU beds (4.2 ICU beds/100,000) found in Portugal and the highest (29.2 ICU beds/100,000) found in Germany. More recently published data supports the finding that Germany has the highest number of ICU beds per 100,000 population; a 2024 Lancet article stated that Germany has over 29 ICU beds for every 100,000 inhabitants, which are among the highest in density within the OECD countries.

Asia Pacific: Increasing Economic Development

The Asia Pacific region has seen rapid growth in ICU capacity due primarily to population growth, increasing economic development and COVID-19 experience. An observational study involving multiple countries, published between 2023 and 2024, shows just how large these increases were; in 2022, thirty-three selected Asian countries had nearly tripled their ICU bed capacity since 2017; they had a combined total of 233,423 ICU beds at an average 9.4 ICU beds per 100,000 residents. These countries have made significant strides to increase their ICU bed capacities through investment from China, India, Japan and South Korea among others; they are doing this in an effort to eliminate longstanding disparities in access to care.

South America: Growing Healthcare Intensity (ICU) Capacity

South America will be pulled into this growing region. Like Brazil, there will be Healthcare Intensity (ICU) Capacity. Between huge growth in several nations, and almost all still suffering some variation of equity gaps and economic weakness. The Organization for Economic Co-operation and Development (OECD)/Pan American Health Organization (PAHO) report "Health at a Glance Latin America and the Caribbean 2023” showed that there exists a large range of variation in the availability of high complexity and Intensive Care (ICU) Beds in Latin America. For example, Brazil's hospital Bed Availability is approximately 20.6 beds per 100,000 people while Colombia's is 10.5 beds. Paraguay's Bed Availability is 10.3 Beds, compared to the much lower numbers for Chile at 7.3 beds and Costa Rica at 2.7. While many of the countries with higher Availability experienced high numbers of Excess Mortality as a consequence of COVID-19, due to the underlying quality of care and access, the differences in Healthcare Delivery System Organization from one country to the next are what account for the difference between Excess Mortality levels among these countries.

Middle East & Africa: Emerging Healthcare Intensity (ICU) Capacity

The MEA has the largest gaps for ICU availability of any region worldwide; While some countries within the Gulf region are trending toward the European levels in numbers of available beds/ICU's; several African nations still exist with major deficits in ICU capacity and/or resources. The most recent evaluation of Africa, conducted through a multi-national study on ICU beds available in 54 nations, supported an estimated average of approximately 2.42 beds/100,000 people. As indicated from the summary of the information collected, ICU bed density varies greatly throughout Africa; for example, the average density in low-income African nations is around 0.14 beds per 100,000 population while an upper middle-income country has a density of approximately 2.49 beds per 100,000 population. In addition, there is an extreme deficiency of life support systems such as ventilators available in both West and East Africa; for example, only 1.10 beds/100,000 and only 0.23 ventilators/100,000 people, respectively. A 2023 review article examining the landscape of critical care in Sub-Saharan Africa, identifies not only the hardware (ventilators, oxygen, and monitors) as major barriers/restrictions but also people trained ICU personnel as an additional barrier in order to develop ICU services and support systems necessary to expand the number of functional ICUs.

Many global, regional, and local vendors characterize the Intensive Care Unit Market. The market is highly competitive, with all the players competing to gain market share. Intense competition, rapid advances in technology, frequent changes in government policies, and environmental regulations are key factors that confront market growth. The vendors compete based on cost, product quality, reliability, and government regulations. Vendors must provide cost-efficient, high-quality products to survive and succeed in an intensely competitive market.
 
The major players in the market Include Getinge AB, Baxter International, Koninklijke Philips N.V., Medtronic, ICU Medical Inc., GE Healthcare, Stryker Corporation, strategic market developments and decisions to improve operational effectiveness.